Last reviewed · How we verify
NCT06965634
Investigation of the Effectiveness of Lung Ultrasonography in Intraoperative Fluid Management
trial testing Lung ultrasound in Intraoperative Fluid Management in 50 participants. Not yet recruiting.
20 May 2026
Quick facts
| Lead sponsor | Korgün Ökmen |
|---|---|
| Status | Not yet recruiting |
| Study type | OBSERVATIONAL |
| Enrollment | 50 |
| Start date | 20 May 2025 |
| Primary completion | 20 May 2026 |
| Estimated completion | 30 May 2026 |
Drugs / interventions tested
- Lung ultrasound
Conditions studied
- Intraoperative Fluid Management — all drugs for Intraoperative Fluid Management →
Sponsor
Korgün Ökmen
Who can join
Adults 18 to 80, any sex, with Intraoperative Fluid Management. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Adequate and balanced fluid resuscitation is one of the cornerstones of intraoperative patient management. Over-resuscitation leading to positive fluid balance is associated with increased postoperative mortality and morbidity. Invasive and non-invasive technologies can be used for the adequacy of intraoperative fluid therapy. Lung ultrasonography (LUS) is a safe and accurate bedside imaging method. LUS, which is frequently used in the diagnosis of postoperative hypoxemia, has also begun to be preferred for fluid management in intensive care units.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06965634
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Lung ultrasound
Trials testing the same drug.
- NCT07442669 — Utilization of Lung Ultrasound Score in Decision for Minimally Invasive Surfactant Administration · NA · not yet recruiting
- NCT07261956 — Lung Ultrasound for the Detection of Volume Overload in Patients With Severe Preeclampsia · NA · recruiting
- NCT06984120 — Increased Extravascular Lung Water in Asymptomatic Open-water Swimmers · completed
- NCT06584474 — THE EFFECT OF NEBULIZED AZITHROMYCIN AS THERAPY FOR BRONCHOPULMONARY DYSPLASIA · Phase 4 · completed
- NCT06555757 — Utilising AI Analysis of Sounds To prEdict heaRt failurE decOmpensation · not yet recruiting
Other Korgün Ökmen trials
Trials by the same sponsor.
- NCT06229782 — Orbital Artery Doppler Ultrasound in Brain Death · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06965634 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Korgün Ökmen
- Last refreshed: 15 May 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06965634.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing